Enteral Feeding Devices Market by Type (Feeding Tubes, Pumps: Feeding, Syringes; Consumables), Age, Application, End User - Global Forecast to 2030
세계의 경장영양 디바이스 시장은 2025년 29억 6,510만 달러에서 2030년에는 39억 9,420만 달러에 달할 것으로 예측됩니다. 이러한 시장 확대는 의료 기술의 발전으로 경장영양 시스템이 더 안전하고 효과적이며 간병인과 가족이 관리하기 쉬워진 것이 주요 요인으로 작용하고 있습니다. 의료 당국의 엄격한 사양은 이러한 시스템이 높은 안전 및 효율성 기준을 충족하도록 보장합니다. 시장 성장에 기여하는 다른 요인으로는 업계 내 경쟁, 인구 통계학적 변화, 경제적 요인, 세계화, 환자 중심 설계, 디지털 통합, 지속가능성 고려 등이 있습니다.
| 조사 범위 |
| 조사 대상연도 |
2024-2030년 |
| 기준연도 |
2024년 |
| 예측 기간 |
2024-2030년 |
| 검토 단위 |
금액(100만 달러) |
| 부문 |
제품별, 연령층별, 용도별, 최종사용자별, 지역별 |
| 대상 지역 |
북미, 유럽, 아시아태평양, 라틴아메리카, 중동 및 아프리카 |
장영양 튜브 부문은 2025-2030년 장영양 장비 시장에서 가장 큰 점유율을 차지할 것으로 예측됩니다. 이러한 추세를 촉진하는 주요 요인으로는 만성질환의 유병률 증가, 노인 인구 증가, 기술의 급속한 발전, 재택치료의 급증, 소아에 대한 적용, 영양 관리에 대한 인식 증가, 규제 대응, 의료비 증가 등이 있습니다. 제조업체들은 이러한 요인들의 변화에 영향을 받으면서 다양한 임상현장에서의 안전성과 사용 편의성을 확보하면서 다양한 환자들의 요구에 부응하기 위해 유연한 기술 혁신을 해야할 것으로 보입니다.
2024년 암 분야는 경장영양장비 시장에서 가장 큰 점유율을 차지할 것으로 예상되며, 이러한 추세는 예측 기간 중 지속될 것으로 예측됩니다. 암 치료 환자의 영양 지원, 수술 후 회복 촉진 프로토콜, 암 관련 영양실조 관리, 기술 발전, 개인별 영양 계획, 완화 치료와 장내 영양의 통합, 경제적 문제, 규제 지원, 환자 교육, 기타 관련 진행 중인 연구 및 개발 등이 암 분야의 장내 영양 공급에 영향을 미치는 요인으로 꼽힙니다. 있습니다. 이러한 요인들은 경장영양의 효과적인 활용을 촉진하고 암 진단과 관련된 환자의 삶의 질과 결과를 개선할 수 있습니다.
병원 및 수술센터는 예측 기간 중 경장영양 장비 시장에서 가장 큰 부문이 될 것으로 예측됩니다. 이러한 시설에서 장내 영양 공급의 사용이 증가하는 이유는 주로 환자 결과에 긍정적인 영향을 미치고 결과적으로 의료 비용을 절감하기 때문입니다. 다른 요인으로는 규제 준수, 기술 발전, 환자 안전 및 편의성 향상, 경장영양에 대한 인식 및 교육 향상, 전자건강기록(EHR)과의 통합, 정부의 구상, 환자 중심 치료 모델, 의료 전문가 간의 협력 등이 있습니다. 이러한 요인들이 발전함에 따라 경장영양은 병원과 수술센터에서 환자 치료에 있으며, 중요한 역할을 계속할 것으로 보입니다.
일본, 인도, 중국, 중국, 한국, 호주, 기타로 구성된 아시아태평양은 예측 기간 중 상당한 성장을 이룰 것으로 예측됩니다. 이 지역은 경장영양 장비 시장 성장률이 눈에 띄게 가속화되고 있습니다. 그 요인으로는 인구 통계학적 변화, 경제 성장, 경제성, 경제성 향상, 기술 발전, 규제 프레임워크, 헬스케어 인식 개선, 헬스케어 서비스 확대, 무역 및 시장 접근성 강화, 다양한 정부 구상 등을 들 수 있습니다. 이러한 요인들이 결합되어 매우 역동적인 시장을 형성하고 있으며, 국내외 기업에게 혁신과 성장 기회를 제공합니다.
세계의 경장영양 디바이스 시장에 대해 조사했으며, 제품별, 연령층별, 용도별, 최종사용자별, 지역별 동향 및 시장에 참여하는 기업의 개요 등을 정리하여 전해드립니다.
목차
제1장 서론
제2장 조사 방법
제3장 개요
제4장 주요 인사이트
제5장 시장 개요
- 서론
- 시장 역학
- Porter's Five Forces 분석
- 규제 상황
- 상환 시나리오
- 에코시스템 분석
- 투자와 자금조달 시나리오
- 기술 분석
- 밸류체인 분석
- 공급망 분석
- 가격 분석
- 특허 분석
- 무역 분석
- 2025-2026년의 주요 컨퍼런스와 이벤트
- 고객 비즈니스에 영향을 미치는 동향과 혼란
- 주요 이해관계자와 구입 기준
- 미충족 요구와 주요 문제점
- 경장영양 디바이스 시장에서 AI의 영향
제6장 경장영양 디바이스 시장(제품별)
- 서론
- 경장영양 튜브
- 경장영양 펌프
- 경장 시린지 펌프
- 소모품과 액세서리
제7장 경장영양 디바이스 시장(연령층별)
- 서론
- 신생아 환자
- 소아 환자
- 성인 환자
- 고령 환자
제8장 경장영양 디바이스 시장(용도별)
- 서론
- 종양학
- 위장 장애
- 신경질환
- 당뇨병
- 대사장애
- 기타
제9장 경장영양 디바이스 시장(최종사용자별)
- 서론
- 병원과 외과 센터
- 홈케어
- 외래 진료 환경
- 기타
제10장 경장영양 디바이스 시장(지역별)
- 서론
- 북미
- 유럽
- 거시경제 전망
- 독일
- 프랑스
- 영국
- 이탈리아
- 스페인
- 기타
- 아시아태평양
- 거시경제 전망
- 중국
- 일본
- 인도
- 호주
- 한국
- 기타
- 라틴아메리카
- 중동 및 아프리카
제11장 경쟁 구도
- 서론
- 주요 참여 기업의 전략/강점, 2020-2024년
- 매출 분석, 2020-2024년
- 시장 점유율 분석, 2024년
- 기업 평가 매트릭스 : 주요 참여 기업, 2024년
- 기업 평가 매트릭스 : 스타트업/중소기업, 2024년
- 기업 평가와 재무 지표
- 제품/브랜드 비교
- 경쟁 시나리오
제12장 기업 개요
- 주요 참여 기업
- FRESENIUS SE & CO. KGAA
- CARDINAL HEALTH
- NESTLE S.A.
- AVANOS MEDICAL, INC.
- DANONE S.A.
- BOSTON SCIENTIFIC CORPORATION
- BECTON, DICKINSON AND COMPANY
- B. BRAUN MELSUNGEN AG
- CONMED CORPORATION
- COOK MEDICAL
- MOOG, INC.
- BAXTER INTERNATIONAL INC.
- VYGON
- ENTERAL ACCESS TECHNOLOGIES LTD.
- FIDMI MEDICAL
- LIFEPUM MEDITECH
- 기타 기업
- APPLIED MEDICAL TECHNOLOGY, INC.
- AMSINO INTERNATIONAL, INC.
- OMEX MEDICAL TECHNOLOGY
- DANUMED MEDIZINTECHNIK GMBH.
- MEDLINE INDUSTRIES
- FUJI SYSTEMS CORPORATION
- KENTEC MEDICAL.
- DYNAREX CORPORATION
- VESCO MEDICAL, LLC
- MEDELA AG
- ALCOR SCIENTIFIC
- ROMSONS
제13장 부록
KSA
The global market for enteral feeding devices is projected to reach USD 3,994.2 million by 2030, from USD 2,965.1 million in 2025. This expansion is largely driven by advancements in medical technology, which have made enteral feeding systems safer, more effective, and easier for caregivers and family members to manage. Rigorous specifications from healthcare authorities ensure that these systems meet high standards of safety and efficiency. Other factors contributing to market growth include competition within the industry, demographic shifts, economic factors, globalization, patient-centered design, digital integration, and sustainability considerations.
| Scope of the Report |
|---|
| Years Considered for the Study | 2024-2030 |
| Base Year | 2024 |
| Forecast Period | 2024-2030 |
| Units Considered | Value (USD million) |
| Segments | Product, Age group, Application, End User, and Region |
| Regions covered | North America, Europe, Asia Pacific, Latin America, and Middle East & Africa |
"Enteral feeding tubes to be largest segment during forecast period"
The enteral feeding tubes segment is projected to hold the largest share of the enteral feeding devices market between 2025 and 2030. Key factors driving this trend include the increased prevalence of chronic illnesses, the rise in geriatric population, rapid advancements in technology, a surge in home health care, pediatric applications, heightened awareness of nutritional management, compliance with regulations, and increased health care spending. Manufacturers will need to innovate flexibly to meet diverse patient needs while ensuring safety and usability in various clinical settings, influenced by the global evolution of these factors.
"Oncology to surpass other applications during forecast period"
In 2024, the oncology segment accounted for the largest share of the enteral feeding devices market, and this trend is expected to continue during the forecast period. The factors influencing enteral feeding practices in oncology include nutritional support for the cancer treatment patient, enhanced recovery after surgery protocol, management of cancer-related malnutrition, technological advances, individualized nutritional planning, integration of enteral feeding with palliative care, economic issues, regulatory support, patient education, and other related ongoing research and development. These factors facilitate the effective utilization of enteral feeding to enhance the patient's quality of life and outcomes pertaining to a cancer diagnosis.
"Hospitals & surgical centers segment to be prevalent during forecast period"
Hospitals & surgical centers are expected to be the largest segment in the enteral feeding devices market during the forecast period. The increasing use of enteral feeding in these facilities is primarily due to its positive impact on patient outcomes and the resulting cost savings in healthcare. Other contributing factors include compliance with regulations, advancements in technology, enhancements in patient safety and comfort, increased awareness and education about enteral feeding, integration with electronic health records (EHR), government initiatives, patient-centered care models, and collaboration among healthcare professionals. As these factors evolve, enteral feeding will continue to play a crucial role in patient care in hospitals and surgical centers.
"Asia Pacific to register significant growth during forecast period"
The Asia Pacific region, comprising Japan, India, China, South Korea, Australia, and the Rest of Asia Pacific, is anticipated to experience substantial growth during the forecast period. The region has experienced a notable acceleration in the market growth rate for enteral feeding devices. Contributing factors include demographic changes, economic growth, increased affordability, advancements in technology, regulatory frameworks, improved healthcare awareness, the expansion of healthcare services, enhanced trade and market access, and various government initiatives. Together, these factors create a highly dynamic market that fosters innovation and growth opportunities for both local and international companies.
A breakdown of the primary participants referred to for this report is provided below:
- By Company Type: Tier 1 - 40%, Tier 2 - 30%, and Tier 3 - 30%
- By Designation: C-level -- 27%, Director-level - 18%, and Others - 55%
- By Region: North America - 50%, Europe - 20%, Asia Pacific - 15%, Latin America - 10%, and Middle East & Africa - 5%
Prominent players in this market are Fresenius SE & Co. KGAA. (Germany), Cardinal Health, Inc. (US), Avanos Medical, Inc. (US), Becton, Dickinson and Company (US), B. Braun Melsungen AG (Germany), CONMED Corporation (US), Cook Medical (US), Boston Scientific Corporation (US), and Baxter International Inc. (US), among others.
Research Coverage
- The report studies the enteral feeding devices market based on product, age group, application, end user, and region.
- The report analyzes drivers, restraints, opportunities, and challenges affecting the market growth.
- The report evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders.
- The report studies micro markets with respect to their growth trends, prospects, and contributions to the overall market.
- The report forecasts the revenue of market segments with respect to five major regions.
Key Benefits of Buying this Report:
The report aims to assist new entrants, smaller firms, and market leaders in evaluating investment opportunities within the enteral feeding devices market. It offers a thorough analysis of comprehensive data, enabling informed investment decisions and effective risk assessment. By providing detailed market segmentation that includes end-user categories and regional considerations, the report offers tailored insights for precise targeting of specific segments. Additionally, it delivers an extensive evaluation of key trends, challenges, growth factors, and opportunities, empowering strategic decision-making with a clear understanding.
The report provides insights on the following pointers:
- Market Dynamics: Analysis of key drivers, restraints, opportunities, and challenges influencing the growth of the enteral feeding devices market
- Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and product & service launches in the enteral feeding devices market
- Market Development: Comprehensive information about lucrative markets
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the enteral feeding devices market
- Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players like Fresenius SE & Co. KGAA. (Germany), Cardinal Health, Inc. (US), Avanos Medical, Inc. (US), Becton, Dickinson and Company (US), B. Braun Melsungen AG (Germany), CONMED Corporation (US), Cook Medical (US), Boston Scientific Corporation (US), and Baxter International Inc. (US), among others
TABLE OF CONTENTS
1 INTRODUCTION
- 1.1 STUDY OBJECTIVES
- 1.2 MARKET DEFINITION
- 1.3 STUDY SCOPE
- 1.3.1 MARKETS COVERED AND REGIONAL SCOPE
- 1.3.2 INCLUSIONS AND EXCLUSIONS
- 1.3.3 YEARS CONSIDERED
- 1.4 CURRENCY CONSIDERED
- 1.5 STAKEHOLDERS
- 1.6 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
- 2.1 RESEARCH DATA
- 2.1.1 SECONDARY RESEARCH
- 2.1.1.1 List of secondary sources
- 2.1.1.2 Key data from secondary sources
- 2.1.1.3 Objectives of secondary research
- 2.1.2 PRIMARY RESEARCH
- 2.1.2.1 List of primary sources (demand and supply sides)
- 2.1.2.2 Supply- and demand-side participants
- 2.1.2.3 Breakdown of primary interviews (supply side)
- 2.1.2.4 Breakdown of primary interviews (demand side)
- 2.1.2.5 Objectives of primary research
- 2.2 MARKET SIZE ESTIMATION
- 2.2.1 BOTTOM-UP APPROACH
- 2.2.1.1 Approach 1: Company revenue estimation
- 2.2.1.2 Approach 2: Customer-based market estimation
- 2.2.1.3 Approach 3: Primary interviews
- 2.2.2 TOP-DOWN APPROACH
- 2.3 GROWTH FORECAST ASSUMPTIONS
- 2.4 DATA TRIANGULATION
- 2.5 RESEARCH ASSUMPTIONS
- 2.6 RESEARCH LIMITATIONS
- 2.7 RISK ASSESSMENT
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
- 4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN ENTERAL FEEDING DEVICES MARKET
- 4.2 ENTERAL FEEDING DEVICES MARKET, BY REGION
- 4.3 US ENTERAL FEEDING DEVICES MARKET, BY COUNTRY AND END USER
- 4.4 ENTERAL FEEDING DEVICES MARKET, BY COUNTRY
5 MARKET OVERVIEW
- 5.1 INTRODUCTION
- 5.2 MARKET DYNAMICS
- 5.2.1 DRIVERS
- 5.2.1.1 Benefits and cost-effectiveness of enteral nutrition
- 5.2.1.2 High incidence of preterm births and genetic disorders in pediatric and neonatal patients
- 5.2.1.3 Rapid growth in geriatric population and age-related chronic diseases
- 5.2.1.4 Increasing prevalence of dysphagia
- 5.2.2 RESTRAINTS
- 5.2.2.1 Complications associated with enteral feeding devices
- 5.2.2.2 Lack of awareness about feeding tubes
- 5.2.3 OPPORTUNITIES
- 5.2.3.1 High growth opportunities in emerging economies
- 5.2.3.2 Growing demand for enteral feeding in home care settings
- 5.2.4 CHALLENGES
- 5.2.4.1 Insufficient reimbursement policies in emerging economies
- 5.2.4.2 Shortage of endoscopy specialists
- 5.3 PORTER'S FIVE FORCES ANALYSIS
- 5.3.1 THREAT OF NEW ENTRANTS
- 5.3.2 THREAT OF SUBSTITUTES
- 5.3.3 BARGAINING POWER OF SUPPLIERS
- 5.3.4 BARGAINING POWER OF BUYERS
- 5.3.5 INTENSITY OF COMPETITIVE RIVALRY
- 5.4 REGULATORY LANDSCAPE
- 5.4.1 REGULATORY ANALYSIS
- 5.4.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- 5.5 REIMBURSEMENT SCENARIO
- 5.6 ECOSYSTEM ANALYSIS
- 5.7 INVESTMENT AND FUNDING SCENARIO
- 5.8 TECHNOLOGY ANALYSIS
- 5.8.1 KEY TECHNOLOGIES
- 5.8.1.1 Flow generation mechanisms
- 5.8.1.2 Flow control technologies
- 5.8.2 COMPLEMENTARY TECHNOLOGIES
- 5.8.2.1 Smart feeding pumps
- 5.8.2.2 Feeding tube replacement technologies
- 5.8.3 ADJACENT TECHNOLOGIES
- 5.8.3.1 Patient monitoring systems
- 5.8.3.2 Digital connectivity
- 5.8.3.3 Nutrition supplements
- 5.9 VALUE CHAIN ANALYSIS
- 5.9.1 RESEARCH AND DEVELOPMENT
- 5.9.2 RAW MATERIAL PROCUREMENT AND PRODUCT MANUFACTURING
- 5.9.3 DISTRIBUTION, MARKETING AND SALES, AND AFTER-SALES SERVICES
- 5.10 SUPPLY CHAIN ANALYSIS
- 5.10.1 PROMINENT COMPANIES
- 5.10.2 SMALL AND MEDIUM-SIZED ENTERPRISES
- 5.10.3 END USERS
- 5.11 PRICING ANALYSIS
- 5.11.1 AVERAGE SELLING PRICE TREND, BY PRODUCT
- 5.11.2 AVERAGE SELLING PRICE TREND OF ENTERAL FEEDING DEVICES OFFERED BY KEY PLAYERS
- 5.11.3 AVERAGE SELLING PRICE TREND, BY REGION
- 5.12 PATENT ANALYSIS
- 5.13 TRADE ANALYSIS
- 5.13.1 IMPORT SCENARIO (HS CODE 901839)
- 5.13.2 EXPORT SCENARIO (HS CODE 901839)
- 5.14 KEY CONFERENCES AND EVENTS, 2025-2026
- 5.15 TRENDS AND DISRUPTIONS IMPACTING CUSTOMER BUSINESS
- 5.16 KEY STAKEHOLDERS AND BUYING CRITERIA
- 5.16.1 KEY STAKEHOLDERS IN BUYING PROCESS
- 5.16.2 BUYING CRITERIA
- 5.17 UNMET NEEDS AND KEY PAIN POINTS
- 5.18 IMPACT OF AI ON ENTERAL FEEDING DEVICES MARKET
6 ENTERAL FEEDING DEVICES MARKET, BY PRODUCT
- 6.1 INTRODUCTION
- 6.2 ENTERAL FEEDING TUBES
- 6.2.1 NASAL FEEDING TUBES
- 6.2.1.1 Need for short-term feeding with minimal tube replacement to drive market
- 6.2.2 ORAL FEEDING TUBES
- 6.2.2.1 Extensive use in feeding preterm babies to drive market
- 6.2.3 GASTRIC OR GASTROSTOMY TUBES (G-TUBES)
- 6.2.3.1 Escalating demand for PEG and PRG tubes to drive market
- 6.2.4 JEJUNOSTOMY TUBES (J-TUBES)
- 6.2.4.1 Trend of minimally invasive procedures to drive market
- 6.2.5 GASTROSTOMY-JEJUNOSTOMY TUBES (GJ-TUBES)
- 6.2.5.1 Reduced tube dislodgment and user-friendly feeding to drive market
- 6.3 ENTERAL FEEDING PUMPS
- 6.3.1 RAPID GROWTH IN HOME HEALTHCARE TO DRIVE MARKET
- 6.4 ENTERAL SYRINGE PUMPS
- 6.4.1 RELIANCE ON TUBE FEEDING TO DRIVE MARKET
- 6.5 CONSUMABLES & ACCESSORIES
- 6.5.1 SYRINGES
- 6.5.1.1 Technological improvements to drive market
- 6.5.2 EXTENSION SETS
- 6.5.2.1 Safe and flexible delivery of nutrition, fluids, and medications to drive market
- 6.5.3 ADAPTERS
- 6.5.3.1 Focus on biocompatible materials and minimally invasive designs to drive market
- 6.5.4 NUTRITION STRAWS
- 6.5.4.1 Emergence of home enteral nutrition programs to drive market
7 ENTERAL FEEDING DEVICES MARKET, BY AGE GROUP
- 7.1 INTRODUCTION
- 7.2 NEONATAL PATIENTS
- 7.2.1 RISE IN PRETERM BIRTHS TO DRIVE MARKET
- 7.3 PEDIATRIC PATIENTS
- 7.3.1 HEIGHTENED CONCERNS OF MALNUTRITION TO DRIVE MARKET
- 7.4 ADULT PATIENTS
- 7.4.1 HIGH BURDEN OF CHRONIC DISEASES TO DRIVE MARKET
- 7.5 GERIATRIC PATIENTS
- 7.5.1 DEMOGRAPHIC TRENDS AND TECHNOLOGICAL ADVANCEMENTS TO DRIVE MARKET
8 ENTERAL FEEDING DEVICES MARKET, BY APPLICATION
- 8.1 INTRODUCTION
- 8.2 ONCOLOGY
- 8.2.1 INCREASED PREVALENCE OF CANCER TO DRIVE MARKET
- 8.3 GASTROINTESTINAL DISORDERS
- 8.3.1 RISE OF IRRITABLE BOWEL SYNDROME AND GASTROESOPHAGEAL REFLUX DISEASE TO DRIVE MARKET
- 8.4 NEUROLOGICAL DISORDERS
- 8.4.1 SURGE IN DEMAND FOR CLINICAL NUTRITION THERAPIES TO DRIVE MARKET
- 8.5 DIABETES
- 8.5.1 NEED FOR CONTROLLED ADMINISTRATION OF MEDICATIONS TO DRIVE MARKET
- 8.6 METABOLIC DISORDERS
- 8.6.1 GROWING INCIDENCE OF BURN INJURIES AND SEPSIS TO DRIVE MARKET
- 8.7 OTHER APPLICATIONS
9 ENTERAL FEEDING DEVICES MARKET, BY END USER
- 9.1 INTRODUCTION
- 9.2 HOSPITALS & SURGICAL CENTERS
- 9.2.1 RAPID ADOPTION OF ENTERAL FEEDING DEVICES IN INTENSIVE CARE UNITS TO DRIVE MARKET
- 9.3 HOME CARE
- 9.3.1 SUBSTANTIAL HOSPITALIZATION COSTS TO DRIVE MARKET
- 9.4 AMBULATORY CARE SETTINGS
- 9.4.1 ELEVATED DEMAND FOR SPECIALTY CARE TO DRIVE MARKET
- 9.5 OTHER END USERS
10 ENTERAL FEEDING DEVICES MARKET, BY REGION
- 10.1 INTRODUCTION
- 10.2 NORTH AMERICA
- 10.2.1 MACROECONOMIC OUTLOOK
- 10.2.2 US
- 10.2.2.1 Presence of major enteral feeding device providers to drive market
- 10.2.3 CANADA
- 10.2.3.1 Increasing incidence of chronic diseases such as diabetes and cancer to drive market
- 10.3 EUROPE
- 10.3.1 MACROECONOMIC OUTLOOK
- 10.3.2 GERMANY
- 10.3.2.1 Government initiatives enhancing domestic healthcare system to drive market
- 10.3.3 FRANCE
- 10.3.3.1 Escalating demand for early disease diagnosis to drive market
- 10.3.4 UK
- 10.3.4.1 Substantial rise in cancer and neurological disorders to drive market
- 10.3.5 ITALY
- 10.3.5.1 Elevated demand for cost-effective home care solutions to drive market
- 10.3.6 SPAIN
- 10.3.6.1 Surge in patients opting for enteral nutrition to drive market
- 10.3.7 REST OF EUROPE
- 10.4 ASIA PACIFIC
- 10.4.1 MACROECONOMIC OUTLOOK
- 10.4.2 CHINA
- 10.4.2.1 Growing investments in healthcare infrastructure development to drive market
- 10.4.3 JAPAN
- 10.4.3.1 Rapidly expanding geriatric population to drive market
- 10.4.4 INDIA
- 10.4.4.1 Large patient pool and increased per capita income to drive market
- 10.4.5 AUSTRALIA
- 10.4.5.1 Soaring volume of patients to drive market
- 10.4.6 SOUTH KOREA
- 10.4.6.1 Large number of private hospitals to drive market
- 10.4.7 REST OF ASIA PACIFIC
- 10.5 LATIN AMERICA
- 10.5.1 MACROECONOMIC OUTLOOK
- 10.5.2 BRAZIL
- 10.5.2.1 Improving healthcare facilities to drive market
- 10.5.3 MEXICO
- 10.5.3.1 Robust healthcare system with universal health coverage to drive growth
- 10.5.4 REST OF LATIN AMERICA
- 10.6 MIDDLE EAST & AFRICA
- 10.6.1 MACROECONOMIC OUTLOOK
- 10.6.2 GCC COUNTRIES
- 10.6.3 REST OF MIDDLE EAST & AFRICA
11 COMPETITIVE LANDSCAPE
- 11.1 INTRODUCTION
- 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2020-2024
- 11.3 REVENUE ANALYSIS, 2020-2024
- 11.4 MARKET SHARE ANALYSIS, 2024
- 11.4.1 ENTERAL FEEDING TUBES MARKET SHARE
- 11.4.2 ENTERAL FEEDING PUMPS MARKET SHARE
- 11.4.3 ENTERAL SYRINGE PUMPS MARKET SHARE
- 11.4.4 CONSUMABLES & ACCESSORIES MARKET SHARE
- 11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
- 11.5.1 STARS
- 11.5.2 EMERGING LEADERS
- 11.5.3 PERVASIVE PLAYERS
- 11.5.4 PARTICIPANTS
- 11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
- 11.5.5.1 Company footprint
- 11.5.5.2 Region footprint
- 11.5.5.3 Product footprint
- 11.5.5.4 Application footprint
- 11.5.5.5 Age group footprint
- 11.5.5.6 End user footprint
- 11.6 COMPANY EVALUATION MATRIX: START-UPS/SMES, 2024
- 11.6.1 PROGRESSIVE COMPANIES
- 11.6.2 RESPONSIVE COMPANIES
- 11.6.3 DYNAMIC COMPANIES
- 11.6.4 STARTING BLOCKS
- 11.6.5 COMPETITIVE BENCHMARKING: START-UPS/SMES, 2024
- 11.6.5.1 List of start-ups/SMEs
- 11.6.5.2 Competitive benchmarking of start-ups/SMEs
- 11.7 COMPANY VALUATION AND FINANCIAL METRICS
- 11.8 PRODUCT/BRAND COMPARISON
- 11.9 COMPETITIVE SCENARIO
- 11.9.1 PRODUCT LAUNCHES AND APPROVALS
- 11.9.2 DEALS
12 COMPANY PROFILES
- 12.1 KEY PLAYERS
- 12.1.1 FRESENIUS SE & CO. KGAA
- 12.1.1.1 Business overview
- 12.1.1.2 Products offered
- 12.1.1.3 Recent developments
- 12.1.1.3.1 Expansions
- 12.1.1.3.2 Other developments
- 12.1.1.4 MnM view
- 12.1.1.4.1 Key strengths
- 12.1.1.4.2 Strategic choices
- 12.1.1.4.3 Weaknesses and competitive threats
- 12.1.2 CARDINAL HEALTH
- 12.1.2.1 Business overview
- 12.1.2.2 Products offered
- 12.1.2.3 Recent developments
- 12.1.2.3.1 Product launches and approvals
- 12.1.2.3.2 Deals
- 12.1.2.4 MnM view
- 12.1.2.4.1 Key strengths
- 12.1.2.4.2 Strategic choices
- 12.1.2.4.3 Weaknesses and competitive threats
- 12.1.3 NESTLE S.A.
- 12.1.3.1 Business overview
- 12.1.3.2 Products offered
- 12.1.3.3 MnM view
- 12.1.3.3.1 Key strengths
- 12.1.3.3.2 Strategic choices
- 12.1.3.3.3 Weaknesses and competitive threats
- 12.1.4 AVANOS MEDICAL, INC.
- 12.1.4.1 Business overview
- 12.1.4.2 Products offered
- 12.1.4.3 Recent developments
- 12.1.4.3.1 Product launches and approvals
- 12.1.4.3.2 Expansions
- 12.1.4.4 MnM view
- 12.1.4.4.1 Key strengths
- 12.1.4.4.2 Strategic choices
- 12.1.4.4.3 Weaknesses and competitive threats
- 12.1.5 DANONE S.A.
- 12.1.5.1 Business overview
- 12.1.5.2 Products offered
- 12.1.5.3 Recent developments
- 12.1.5.4 MnM view
- 12.1.5.4.1 Key strengths
- 12.1.5.4.2 Strategic choices
- 12.1.5.4.3 Weaknesses and competitive threats
- 12.1.6 BOSTON SCIENTIFIC CORPORATION
- 12.1.6.1 Business overview
- 12.1.6.2 Products offered
- 12.1.6.3 Recent developments
- 12.1.6.3.1 Deals
- 12.1.6.3.2 Expansions
- 12.1.7 BECTON, DICKINSON AND COMPANY
- 12.1.7.1 Business overview
- 12.1.7.2 Products offered
- 12.1.7.3 Recent developments
- 12.1.7.3.1 Product launches and approvals
- 12.1.8 B. BRAUN MELSUNGEN AG
- 12.1.8.1 Business overview
- 12.1.8.2 Products offered
- 12.1.9 CONMED CORPORATION
- 12.1.9.1 Business overview
- 12.1.9.2 Products offered
- 12.1.9.3 Recent developments
- 12.1.10 COOK MEDICAL
- 12.1.10.1 Business overview
- 12.1.10.2 Products offered
- 12.1.11 MOOG, INC.
- 12.1.11.1 Business overview
- 12.1.11.2 Products offered
- 12.1.12 BAXTER INTERNATIONAL INC.
- 12.1.12.1 Business overview
- 12.1.12.2 Products offered
- 12.1.12.3 Recent developments
- 12.1.13 VYGON
- 12.1.13.1 Business overview
- 12.1.13.2 Products offered
- 12.1.13.3 Recent developments
- 12.1.14 ENTERAL ACCESS TECHNOLOGIES LTD.
- 12.1.14.1 Business overview
- 12.1.14.2 Products offered
- 12.1.14.3 Recent developments
- 12.1.14.3.1 Other developments
- 12.1.15 FIDMI MEDICAL
- 12.1.15.1 Business overview
- 12.1.15.2 Products offered
- 12.1.15.3 Recent developments
- 12.1.15.3.1 Product launches and approvals
- 12.1.16 LIFEPUM MEDITECH
- 12.1.16.1 Business overview
- 12.1.16.2 Products offered
- 12.2 OTHER PLAYERS
- 12.2.1 APPLIED MEDICAL TECHNOLOGY, INC.
- 12.2.2 AMSINO INTERNATIONAL, INC.
- 12.2.3 OMEX MEDICAL TECHNOLOGY
- 12.2.4 DANUMED MEDIZINTECHNIK GMBH.
- 12.2.5 MEDLINE INDUSTRIES
- 12.2.6 FUJI SYSTEMS CORPORATION
- 12.2.7 KENTEC MEDICAL.
- 12.2.8 DYNAREX CORPORATION
- 12.2.9 VESCO MEDICAL, LLC
- 12.2.10 MEDELA AG
- 12.2.11 ALCOR SCIENTIFIC
- 12.2.12 ROMSONS
13 APPENDIX
- 13.1 DISCUSSION GUIDE
- 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
- 13.3 CUSTOMIZATION OPTIONS
- 13.4 RELATED REPORTS
- 13.5 AUTHOR DETAILS
